A critical appraisal of mucormycosis in COVID- ۱۹ patients in a tertiary care centre in India

Publish Year: 1402
نوع سند: مقاله ژورنالی
زبان: English
View: 82

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_CUMM-9-1_001

تاریخ نمایه سازی: 9 آذر 1402

Abstract:

Background and Purpose: Morbidity and mortality of opportunistic fungal infections in COVID-۱۹ patients are less studied and defined. The patients receiving immunosuppressive therapy, broad-spectrum antibiotics, corticosteroids, and invasive and non-invasive ventilation are the high-risk groups.Materials and Methods: The demographic profile as well as clinical and radiological findings of all the patients with COVID-۱۹ suspected of Mucormycosis (MM) were recorded. The tissue samples from all the patients were sent for microbiological (KOH mount and culture) and histopathological analysis for confirmation of MM.Results: In total, ۴۵ COVID-۱۹ patients suspected of MM were included in the study an MM was confirmed in ۴۲ patients. The mean age of the patients was ۵۰.۳۰±۱۴.۱۷ years with a female: male ratio of ۱.۱:۱. The most common symptom was headache (۵۲.۳۸%) followed by purulent nasal discharge (۳۸.۰۹%) and facial pain in ۳۳.۳۳% of the cases. The ocular symptoms included a diminution of vision (۳۳.۳۳%) and redness of the eye (۲.۳۸%).The most common site of involvement was rhino-orbital (۴۲.۸۵%) followed by sinonasal (۲۳.۸۰%) and rhino cerebral (۱۹.۰۴%). Majority (۳۸.۰۹%) of the patients were diagnosed with stage II of Rhino-orbital-cerebral Mucormycosis (ROCM) based on radiology. A history of diabetes mellitus and steroids was present in ۹۷.۶۱% and ۸۵.۷۱% of the cases, respectively. Moreover, KOH was positive for MM in ۹۷.۶۱% of the cases while the culture was positive in only ۳۵.۷۱% of the cases. In addition, on histopathology, MM was confirmed in ۶۴.۲۸ % of the cases. Mixed growth with Aspergillus species and Rhizopus species was observed in ۱۴.۲۸% of the cases in culture and ۱۱.۹۰% of the cases in histopathology test. Furthermore, angioinvasion was found in ۲۳.۸۰% of the cases according to the histopathology test.Conclusion: Based on the results, the most common conditions associated with MM in COVID-۱۹ patients were diabetes mellitus and steroid therapy. A high level of clinical suspicion aided with diagnostic tests, including KOH mount, culture, histopathology, and radiology which helped the early detection of opportunistic fungal infection in COVID-۱۹ patients to ensure timely treatment.

Authors

Sujata Raychaudhuri

Department of Pathology, ESIC Medical College and Hospital Faridabad, India

Juhi Taneja

Department of Microbiology, ESIC Medical College and Hospital, Faridabad, India

Jaseetha Sasidharan

Department of Ear, Nose, and Throat, ESIC Medical College and Hospital, Faridabad, India

Mukta Pujani

Department of Pathology, ESIC Medical College and Hospital Faridabad, India

Kanika Singh

Department of Pathology, ESIC Medical College and Hospital Faridabad, India

Tathagata Chatterjee

Department of Pathology, ESIC Medical College and Hospital Faridabad, India

Manjula Jain

Department of Pathology, ESIC Medical College and Hospital Faridabad, India

Rajkumar Chandoke

Department of Pathology, ESIC Medical College and Hospital Faridabad, India

Anil Rai

Department of Ear, Nose, and Throat, ESIC Medical College and Hospital, Faridabad, India

Zafar Abbas

Department of Radio Diagnosis, ESIC Medical College and Hospital, Faridabad, India

Asim Das

Department of Physiology, ESIC Medical college and Hospital, Faridabad, India

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Kubin CJ, McConville TH, Dietz D, Zucker J, May M, ...
  • Song G, Liang G, Liu W. Fungal co-infections associated with ...
  • Eucker J, Sezer O, Graf B, Possinger K. Mucormycoses. Mycoses. ...
  • Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and diagnosis of ...
  • Prakash H, Chakrabarti A. Global epidemiology of mucormycosis. J Fungi ...
  • Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA,Schaufele ...
  • Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, ...
  • Mehta S, Pandey A. Rhino-orbital mucormycosis associated with COVID-۱۹. Cureus. ...
  • Werthman-Ehrenreich A. Mucormycosis with orbital compartment syndrome in a patient ...
  • Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in ...
  • Bouchara JP, Oumeziane NA, Lissitzky JC, Larcher G, Tronchin G,Chabasse ...
  • ۱۹۹۶; ۷۰(۱):۷۶-۸۳ ...
  • Mishra N, Mutya VS, Thomas A, Rai G, Reddy B, ...
  • Singh V, Prasad A, Panda PK, Totaganti M, Tyagi AK, ...
  • Honavar SG. Code mucor: guidelines for the diagnosis, staging and ...
  • Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, ...
  • Selarka L, Sharma S, Saini D, Sharma S, Batra A, ...
  • Ravani SA, Agrawal GA, Leuva PA, Modi PH, Amin KD. ...
  • Chavan RP, Ingole SM, Nazir HA, Desai WV, Kanchewad GS. ...
  • Peterson KL, Wang M, Canalis RF, Abemayor E. Rhinocerebral mucormycosis: ...
  • John TM, Jacob CN, Kontoyiannis DP. When uncontrolled diabetes mellitus ...
  • Vaidya D, Shah P Coinfection by Aspergillus and Zygomycetes species ...
  • Mohanty A, Gupta P, Arathi K, Rao S, Rohilla R, ...
  • Guarner J, Brandt ME. Histopathologic diagnosis of fungal infections in ...
  • Brettholz AM, Mccauley SO. Mucormycosis: Early identification of a deadly ...
  • نمایش کامل مراجع